Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

0
Player Avatar giannelli5 (22.82) Submitted: 8/11/2011 12:59:01 PM : Outperform Start Price: $33.67 LLY Score: +8.51

Good dividend; bought near low

Featured Broker Partners


Advertisement